---
title: "Ocrevus (ocrelizumab), all indications: Storage and supply questions"
description: "Storage and supply questions on Ocrevus (ocrelizumab) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: How supplied. Questions: What are the NDC numbers for Ocrevus and Ocrevus Zunovo? 1 question quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/ocrevus/storage-and-supply"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Ocrevus (ocrelizumab), all indications: Storage and supply questions

Manufacturer: Genentech, Inc.  
Prescribing information: [Ocrevus](https://www.gene.com/download/pdf/ocrevus_prescribing.pdf), [Ocrevus Zunovo](https://www.gene.com/download/pdf/ocrevus_zunovo_prescribing.pdf)  
Indication pages: [Multiple sclerosis](https://www.evicenter.com/medical-information/ocrevus--multiple-sclerosis)

## How supplied

<a id="ocrevus-ndc"></a>

### What are the NDC numbers for Ocrevus and Ocrevus Zunovo?

> “Drug: NDC
> 10-digit 
> 50242-150-01
> Ocrelizumab, 300 mg single-dose vial
> 11-digit 
> 50242-0150-01”

Source: [OCREVUS: Example Coding and Billing for OCREVUS and OCREVUS ZUNOVO, page 2, captured 2026-11-12](https://www.ocrevus-hcp.com/content/dam/gene/ocrevus-hcp/pdfs/coding-and-billing.pdf#page=2)

> “Drug: NDC
> 10-digit 
> 50242-554-01
> Ocrelizumab, 920 mg and hyaluronidase 23,000 units  
> single-dose vial
> 11-digit 
> 50242-0554-01”

Source: [OCREVUS: Example Coding and Billing for OCREVUS and OCREVUS ZUNOVO, page 2, captured 2026-11-12](https://www.ocrevus-hcp.com/content/dam/gene/ocrevus-hcp/pdfs/coding-and-billing.pdf#page=2)

> “The codes on pages 2 and 3 are not all-inclusive for multiple sclerosis; appropriate codes can vary by patient, setting of care and payer. Correct 
> coding is the responsibility of the provider submitting the claim for the item or service. Please check with the payer to verify codes and special 
> billing requirements. Genentech does not make any representation or guarantee concerning reimbursement or coverage for any item or service.”

Source: [OCREVUS: Example Coding and Billing for OCREVUS and OCREVUS ZUNOVO, page 2, captured 2026-11-12](https://www.ocrevus-hcp.com/content/dam/gene/ocrevus-hcp/pdfs/coding-and-billing.pdf#page=2)

Note: The passages are from the example coding and billing document that the payer coverage page links.

## Related pages
- [Medical information: Ocrevus (ocrelizumab): All indications](https://www.evicenter.com/medical-information/ocrevus)
- [Access and coverage](https://www.evicenter.com/medical-information/ocrevus/access-and-coverage)
